4017 | Humans |
3962 | Animals |
2102 | Male |
1607 | Female |
1410 | Mice |
1037 | Rats |
1012 | Models, Biological |
769 | Antineoplastic Agents |
687 | Signal Transduction |
654 | Tumor Necrosis Factor-alpha |
627 | Adult |
591 | Hypoglycemic Agents |
589 | Middle Aged |
585 | Apoptosis |
577 | Insulin |
528 | Cytokines |
511 | Disease Models, Animal |
511 | Cell Line, Tumor |
501 | Anti-Bacterial Agents |
491 | Cells, Cultured |
484 | Dose-Response Relationship, Drug |
459 | Anti-Inflammatory Agents |
446 | Time Factors |
408 | Cell Proliferation |
395 | Mice, Inbred C57BL |
393 | Rats, Sprague-Dawley |
377 | Peptides |
374 | Aged |
372 | Biological Transport |
354 | Immunosuppressive Agents |
353 | Cell Line |
352 | Cell Survival |
339 | Treatment Outcome |
339 | Blood Glucose |
331 | Rats, Wistar |
299 | Inflammation |
297 | Biological Products |
290 | Gene Expression Regulation |
282 | Amino Acid Sequence |
275 | Neoplasms |
271 | Mice, Inbred BALB C |
269 | RNA, Messenger |
268 | Recombinant Proteins |
267 | Neuroprotective Agents |
266 | Molecular Sequence Data |
256 | Biological Availability |
248 | Phosphorylation |
242 | Oxidative Stress |
242 | Antioxidants |
237 | Antibodies, Monoclonal |
233 | Biomarkers |
218 | Antiviral Agents |
217 | Case-Control Studies |
212 | Plant Extracts |
211 | NF-kappa B |
211 | Antirheumatic Agents |
206 | Diabetes Mellitus, Type 2 |
204 | Peptide Fragments |
204 | Microbial Sensitivity Tests |
198 | Liver |
195 | Cyclosporine |
187 | Anti-Inflammatory Agents, Non-Steroidal |
184 | Interleukin-6 |
184 | Glutathione |
182 | Arthritis, Rheumatoid |
179 | In Vitro Techniques |
175 | Tumor Cells, Cultured |
172 | Enzyme Inhibitors |
171 | Lipopolysaccharides |
171 | Gene Expression |
171 | Antifungal Agents |
168 | Blotting, Western |
167 | Administration, Oral |
166 | Adolescent |
162 | Drug Delivery Systems |
160 | Kinetics |
158 | Drug Therapy, Combination |
157 | Bacterial Proteins |
156 | Nitric Oxide |
155 | Structure-Activity Relationship |
155 | Neurons |
155 | Antibodies, Monoclonal, Humanized |
151 | Glucose |
147 | Peptides, Cyclic |
147 | Oligopeptides |
145 | Vascular Endothelial Growth Factor A |
145 | Brain |
144 | Young Adult |
143 | Macrophages |
142 | Reactive Oxygen Species |
142 | Protective Agents |
141 | Plant Diseases |
140 | Gene Expression Regulation, Neoplastic |
138 | Calcium |
137 | Biological Control Agents |
136 | Diabetes Mellitus, Type 1 |
136 | Biological Assay |
135 | Breast Neoplasms |
135 | Anti-Infective Agents |
134 | Mutation |
133 | Caspase 3 |
132 | Cell Movement |
131 | Up-Regulation |
131 | Inflammation Mediators |
130 | Mice, Nude |
129 | Transfection |
128 | Protein Binding |
128 | Pest Control, Biological |
128 | Cell Division |
127 | Interferon-gamma |
127 | Drug Carriers |
125 | Down-Regulation |
121 | Risk Factors |
121 | Mice, Knockout |
121 | Enzyme Activation |
120 | Neurotransmitter Agents |
120 | Antimicrobial Cationic Peptides |
119 | Proto-Oncogene Proteins c-bcl-2 |
119 | Endothelium, Vascular |
118 | Diabetes Mellitus, Experimental |
117 | Neovascularization, Pathologic |
115 | Molecular Structure |
115 | Lung |
113 | Enzyme-Linked Immunosorbent Assay |
112 | Etanercept |
111 | Escherichia coli |
111 | Cell Differentiation |
109 | Xenograft Model Antitumor Assays |
109 | Drug Design |
108 | Insulin Resistance |
108 | Child |
108 | Cell Membrane |
107 | Immunohistochemistry |
106 | Infliximab |
106 | Immunoglobulin G |
104 | Reverse Transcriptase Polymerase Chain Reaction |
104 | Clinical Trials as Topic |
103 | Obesity |
102 | Lipopeptides |
102 | Disease Progression |
101 | T-Lymphocytes |
99 | Rabbits |
99 | Drug Administration Schedule |
99 | Cell Cycle |
99 | Amyloid beta-Peptides |
98 | Mice, Transgenic |
98 | Computer Simulation |
98 | Chromatography, High Pressure Liquid |
97 | Vasodilator Agents |
97 | Nanoparticles |
97 | Mitochondria |
97 | Base Sequence |
97 | Antineoplastic Agents, Phytogenic |
96 | Interleukin-1beta |
96 | Drug Evaluation, Preclinical |
96 | Cattle |
95 | Recombinant Fusion Proteins |
95 | Aged, 80 and over |
94 | Kidney |
94 | Algorithms |
93 | Pregnancy |
93 | Drug Synergism |
93 | Body Weight |
93 | Antihypertensive Agents |
91 | Prospective Studies |
90 | Receptors, Tumor Necrosis Factor |
90 | Phytotherapy |
90 | Fibroblasts |
89 | Blood Pressure |
88 | Retrospective Studies |
88 | Biological Factors |
88 | Bacteria |
88 | Alzheimer Disease |
87 | Swine |
86 | Models, Molecular |
86 | Lung Neoplasms |
85 | Severity of Illness Index |
85 | Proteins |
85 | Protein Kinase Inhibitors |
85 | Immunologic Factors |
85 | Graft Rejection |
84 | Vancomycin |
84 | Proto-Oncogene Proteins c-akt |
84 | Hydrogen-Ion Concentration |
84 | Gene Expression Profiling |
83 | Transcription Factors |
83 | Drug Screening Assays, Antitumor |
83 | Angiogenesis Inhibitors |
81 | Transforming Growth Factor beta |
81 | Hippocampus |
81 | Cardiotonic Agents |
81 | Anticarcinogenic Agents |
80 | Random Allocation |
80 | Interferons |
80 | Interferon-alpha |
80 | Hypertension |
80 | Hyperglycemia |
80 | Adalimumab |
79 | Polyethylene Glycols |
79 | Peptide Hydrolases |
78 | Reproducibility of Results |
77 | Bacillus |
76 | Randomized Controlled Trials as Topic |
76 | Mitogen-Activated Protein Kinases |
76 | DNA |
75 | Phenotype |
75 | Neoplasm Invasiveness |
75 | HeLa Cells |
75 | Area Under Curve |
74 | Drug Resistance, Neoplasm |
74 | Cyclic AMP |
74 | Analysis of Variance |
73 | Myocardium |
73 | Ligands |
73 | Intercellular Signaling Peptides and Proteins |
73 | Flow Cytometry |
73 | Cloning, Molecular |
73 | Cell Death |
72 | Superoxide Dismutase |
72 | Protein-Serine-Threonine Kinases |
72 | Neutrophils |
72 | Methotrexate |
72 | Larva |
72 | Biofilms |
71 | Particle Size |
71 | Biological Transport, Active |
71 | Binding Sites |
70 | Psoriasis |
70 | Molecular Targeted Therapy |
69 | bcl-2-Associated X Protein |
69 | Intracellular Signaling Peptides and Proteins |
69 | Follow-Up Studies |
69 | DNA-Binding Proteins |
69 | Carrier Proteins |
68 | Tissue Distribution |
68 | RNA, Small Interfering |
68 | Neoplasm Proteins |
68 | Fungi |
68 | Endothelial Cells |
68 | Caspases |
67 | Prognosis |
67 | Neuropeptides |
67 | Angiotensin II |
66 | Transcription, Genetic |
66 | Promoter Regions, Genetic |
66 | Nerve Tissue Proteins |
66 | Membrane Proteins |
65 | Staphylococcus aureus |
65 | Neoplasm Metastasis |
65 | Diabetes Mellitus |
64 | Skin |
64 | MAP Kinase Signaling System |
64 | Hypoglycemia |
64 | Doxorubicin |
63 | Lipid Peroxidation |
62 | Oxidation-Reduction |
62 | Flavonoids |
62 | AMP-Activated Protein Kinases |
61 | Virus Replication |
61 | Sequence Analysis, DNA |
61 | Rats, Inbred Strains |
61 | Interleukin-1 |
61 | Fungal Proteins |
61 | Cardiovascular Diseases |
60 | Intestinal Mucosa |
60 | Glycated Hemoglobin A |
60 | Cyclooxygenase 2 |
59 | p38 Mitogen-Activated Protein Kinases |
59 | Phylogeny |
59 | Mass Spectrometry |
59 | Interleukin-2 |
59 | Insulin Secretion |
59 | Epithelial Cells |
59 | Dogs |
58 | Thiazoles |
58 | Prostatic Neoplasms |
58 | Predictive Value of Tests |
58 | Nitric Oxide Synthase Type II |
58 | Nerve Growth Factors |
58 | Energy Metabolism |
58 | Cell Adhesion |
57 | Bacillus subtilis |
56 | Immunity, Innate |
56 | Homeostasis |
56 | DNA Damage |
55 | Matrix Metalloproteinase 9 |
55 | Lipids |
55 | Insect Proteins |
55 | Dietary Supplements |
55 | Adenosine Triphosphate |
54 | Mice, Inbred ICR |
54 | Lymphocyte Activation |
54 | Kidney Transplantation |
54 | Interleukin-10 |
54 | Insulin Infusion Systems |
54 | Cricetinae |
54 | Cisplatin |
54 | Chemistry, Pharmaceutical |
54 | Biological Therapy |
54 | Acetylcholine |
53 | Spleen |
53 | STAT3 Transcription Factor |
53 | Protein Kinase C |
53 | Protein Conformation |
53 | Neoplasm Transplantation |
53 | Inflammatory Bowel Diseases |
53 | Cholesterol |
53 | Brain-Derived Neurotrophic Factor |
53 | Bone Density Conservation Agents |
53 | Antibiosis |
53 | Adipose Tissue |
52 | Vasodilation |
52 | Vasoconstrictor Agents |
52 | Surface-Active Agents |
52 | Polymerase Chain Reaction |
52 | Plasmids |
52 | Plant Leaves |
52 | Insecticides |
52 | Heart |
52 | HEK293 Cells |
52 | Antidepressive Agents |
52 | Amino Acids |
51 | Survival Analysis |
51 | Reperfusion Injury |
51 | Real-Time Polymerase Chain Reaction |
51 | Glucagon-Like Peptide 1 |
51 | Genetic Vectors |
51 | Drug Stability |
51 | Drug Monitoring |
51 | Chronic Disease |
51 | Child, Preschool |
50 | Tumor Suppressor Protein p53 |
50 | Phosphatidylinositol 3-Kinases |
50 | Ovalbumin |
50 | Myocytes, Cardiac |
50 | Injections, Subcutaneous |
50 | Indoles |
50 | HIV Infections |
50 | Drug Interactions |
50 | Dinoprostone |
50 | Asthma |
50 | Animals, Newborn |
49 | Pyridines |
49 | Polymers |
49 | Muscle, Skeletal |
49 | Molecular Weight |
49 | Metformin |
49 | Leukocytes, Mononuclear |
49 | Glucocorticoids |
49 | Gastrointestinal Agents |
49 | Collagen |
49 | Behavior, Animal |
49 | Adipocytes |
48 | Triglycerides |
48 | Thiazolidinediones |
48 | Solubility |
48 | Matrix Metalloproteinase 2 |
48 | Estradiol |
48 | Drug Resistance, Bacterial |
48 | Double-Blind Method |
48 | Combined Modality Therapy |
48 | Apoptosis Regulatory Proteins |
47 | Wound Healing |
47 | Temperature |
47 | Muscle, Smooth, Vascular |
47 | Dexamethasone |
47 | Antineoplastic Agents, Hormonal |
47 | Aging |
46 | Osteoporosis |
46 | Interferon Type I |
46 | Insulin-Secreting Cells |
46 | Chelating Agents |
46 | Adrenal Cortex Hormones |
45 | Staphylococcal Infections |
45 | Protein Structure, Tertiary |
45 | Membrane Glycoproteins |
45 | Intestinal Absorption |
45 | Interleukin-8 |
45 | Glucose Tolerance Test |
45 | Endotoxins |
45 | Brain Ischemia |
45 | Antineoplastic Combined Chemotherapy Protocols |
44 | Tacrolimus |
44 | Risk Assessment |
44 | RNA Interference |
44 | Monocytes |
44 | Malondialdehyde |
44 | Liver Neoplasms |
44 | Hydrogen Peroxide |
44 | Hepatocytes |
44 | Hep G2 Cells |
44 | Glucose Transporter Type 4 |
44 | Genotype |
44 | Ethanol |
44 | ErbB Receptors |
44 | Delayed-Action Preparations |
44 | Caco-2 Cells |
43 | Pyrimidines |
43 | Proto-Oncogene Proteins |
43 | Imidazoles |
43 | Gene Expression Regulation, Bacterial |
43 | Fluorescent Dyes |
43 | Extracellular Signal-Regulated MAP Kinases |
43 | Diet, High-Fat |
42 | Surface Properties |
42 | Species Specificity |
42 | Proteomics |
42 | Permeability |
42 | Nitric Oxide Synthase |
42 | Molecular Docking Simulation |
42 | Liposomes |
42 | Insulin-Like Growth Factor I |
42 | Drug Combinations |
42 | DNA, Bacterial |
42 | Curcumin |
42 | Chemical and Drug Induced Liver Injury |
42 | Cell Nucleus |
42 | Adenocarcinoma |
41 | RAW 264.7 Cells |
41 | Protein Processing, Post-Translational |
41 | Neovascularization, Physiologic |
41 | Microscopy, Fluorescence |
41 | Lipid Metabolism |
41 | Infant, Newborn |
41 | Half-Life |
41 | Genetic Therapy |
41 | Dopamine |
41 | Dermatologic Agents |
41 | Colonic Neoplasms |
41 | Cohort Studies |
41 | Cerebral Cortex |
41 | Cell Transformation, Neoplastic |
41 | CD4-Positive T-Lymphocytes |
41 | Atherosclerosis |
41 | Antibodies |
41 | Adjuvants, Immunologic |
40 | Ultraviolet Rays |
40 | Sulfonamides |
40 | Receptors, G-Protein-Coupled |
40 | MicroRNAs |
40 | Interleukins |
40 | Injections, Intravenous |
40 | Inhibitory Concentration 50 |
40 | Chemokines |
40 | Bone and Bones |
40 | Biomarkers, Tumor |
40 | Bacterial Infections |
39 | Stilbenes |
39 | Sequence Homology, Amino Acid |
39 | Receptors, Cell Surface |
39 | Protease Inhibitors |
39 | Osteoblasts |
39 | Genes, Reporter |
39 | Fusarium |
39 | Electrophoresis, Polyacrylamide Gel |
39 | Drug Compounding |
39 | Anti-Obesity Agents |
39 | Angiotensin-Converting Enzyme Inhibitors |
38 | Sequence Alignment |
38 | Resveratrol |
38 | Paclitaxel |
38 | PPAR gamma |
38 | Osteoclasts |
38 | Microscopy, Confocal |
38 | MCF-7 Cells |
38 | Islets of Langerhans |
38 | Injections, Intraperitoneal |
38 | Immunotherapy |
38 | Eating |
38 | Dipeptides |
38 | Cross-Sectional Studies |
38 | Colorectal Neoplasms |
38 | Colon |
38 | Autophagy |
37 | Virulence |
37 | Tumor Burden |
37 | Transforming Growth Factor beta1 |
37 | Serotonin |
37 | Sensitivity and Specificity |
37 | Radiation-Protective Agents |
37 | Potassium |
37 | Phenols |
37 | Osteogenesis |
37 | Organ Size |
37 | Nuclear Proteins |
37 | Leukocytes |
37 | Leptin |
37 | JNK Mitogen-Activated Protein Kinases |
37 | Incidence |
37 | Hypothalamus |
37 | Genes, Bacterial |
37 | Drug Liberation |
37 | Depsipeptides |
37 | Coloring Agents |
37 | Catalase |
37 | Bradykinin |
36 | Sirolimus |
36 | RANK Ligand |
36 | Plants, Medicinal |
36 | Pancreatic Neoplasms |